Nutrusiyonel Vitamin Eksikliklerinin Nörolojik Bulguları ve Tedavisi

Shea MK, Houston DK, Tooze JA et al. Health, Aging and Body Composition Study. Correlates and prevalence of insufficient 25-hydroxyvitamin D status in black and white older adults: the health, aging and body composition study. J Am Geriatr Soc. 2011 Jul;59:7:1165-74.

Hochberg Z, Bereket A, Davenport M, et al. European Society for Paediatric Endocrinology (ESPE) Bone Club. Consensus development for the supplementation of vitamin D in childhood and adolescence. Horm Res. 2002;58:1:39-51.

Wharton B, Bishop N. Rickets. Lancet. 2003 Oct 25;362:9393:1389-400.

Lee RH, Lyles KW, Colón-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 2010;8:34-46.

Wang Z, Schuetz EG, Xu Y, Thummel KE. Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J Steroid Biochem Mol Biol. 2013;136:54-58.

Nettekoven S, Ströhle A, Trunz B. et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr. 2008 Dec;167:12:1369-77.

Ozkan B. Nutritional rickets in Turkey. Eurasian J Med. 2010 Aug;42:2:86-91.

Bowden SA, Robinson RF, Carr R, Mahan JD. Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics. 2008 Jun;121:6:e1585-90.

Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology. 2011 Oct;134:2:123-39.

Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009 May;65:5 Pt 2:106R-113R.

Richards JB, Valdes AM, Gardner JP, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr. 2007 Nov;86:5:1420-5.

Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007 Jun;85:6:1586-91.

Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007 Mar;103:3-5):708-11.

Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016 Jul;13:7:404-17.

Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010 Jun;39:2:419-46,

Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005 Jan;29:1:21-30.

Bouillon R, Carmeliet G, Verlinden L, e al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29:6:726-76.

Soni M, Kos K, Lang IA, Jones K, Melzer D, Llewellyn DJ. Vitamin D and cognitive function. Scand J Clin Lab Invest Suppl. 2012;243:79-82.

Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008 Oct;65:10:1348-52.

Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008 May;65:5:508-12.

Manappallil RG, Krishnan R, Veetil PP, et al. Hypocalcemic Seizure Due to Vitamin D Deficiency. Indian J Crit Care Med. 2020 Sep;24:9:882-84.

Cannell JJ. Vitamin D and autism, what's new? Rev Endocr Metab Disord. 2017 Jun;18:2:183-193.

Hatun Ş, Bereket A, Çalıkoğlu AS, Özkan B. Günümüzde D vitamini yetersizliği ve nütrisyonel rikets. Çocuk Sağlığı ve Hastalıkları Dergisi 2003;463:224-241.

Ramasamy I. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. Clin Biochem Rev. 2020 Dec;41:3:103-126.

Scott JM, Molloy AM. The discovery of vitamin B(12). Ann Nutr Metab. 2012;61:239–45.

Rush EC, Katre P, Yajnik CS. Vitamin B12: one carbon metabolism, fetal growth and programming for chronic disease. Eur J Clin Nutr. 2014; 68:2–7.

Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur J Clin Nutr 2014;68:541-8.

Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008;29:20–34.

Baumgartner RM. Vitamin-Responsive Disorders: Cobalamin, Folate, Biotin, Vitamins B1 and E. Dulac O, Lassonde M, Sarnat HB, editors. Pediatric Neurology Part III. 3rd series. Amsterdam: Handbook of Clinical Neurology;2013.p.1799-1817.

Serin HM, Arslan EA. Neurological symptoms of vitamin B12 deficiency: analysis of pediatric patients. Acta Clin Croat. 2019 Jun;58:2:295-302.

Akcaboy M, Malbora B, Zorlu P, Altınel E, Oguz MM, Senel S. Vitamin B12 Deficiency in Infants. Indian J Pediatr. 2015 Jul;82:7:619-24.

Calik M, Aktas MS, Cecen E, et al. The association between serum vitamin B12 deficiency and tension-type headache in Turkish children. Neurol Sci. 2018 Jun;39:6:1009-14.

Yetley EA, Pfeiffer CM, Phinney KW, et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr 2011;94:313S–21S.

Briani C, Dalla Torre C, Citton V, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients 2013;5:4521–39.

Ekici F, Tekbas G, Hattapoğlu S, Yaramış A, Önder H, Bilici A. Brain MRI and MR Spectroscopy Findings in Children with Nutritional Vitamin B12 Deficiency. Clin Neuroradiol. 2016 Jun;26:2:215-20.

Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol. 2006;134:125–36.

Rasmussen SA, Fernhoff PM, Scanlon KS. Vitamin B12 deficiency in children and adolescents. J Pediatr. 2001 Jan;138:10-7.

Incecik F, Hergüner MO, Altunbaşak S, Leblebisatan G. Neurologic findings of nutritional vitamin B12 deficiency in children. Turk J Pediatr. 2010 Jan-Feb;52:1:17-21.

Sezgin Evim M, Erdöl Ş, Özdemir Ö, Baytan B, Güneş AM. Long-term outcome in children with nutritional vitamin B12 deficiency. Turk J Haematol. 2011 Dec 5;28:4:286-93.

Gupte S, Pal M, Gupta SK, Sangra KR. Infantile tremor syndrome (ITS). Gupte S, editors. Textbook of Paediatric Nutrition. 3th edn. New Delhi; 2006. p. 255–265.

Avci Z, Turul T, Aysun S, Unal I. Involuntary movements and magnetic resonance imaging findings in infantile cobalamine (vitamin B12) deficiency. Pediatrics. 2003 Sep;112(3 Pt 1):684-6.

Vora RM, Tullu MS, Bartakke SP, Kamat JR. Infantile tremor syndrome and zinc deficiency. Indian J Med Sci. 2002 Feb;56:2:69-72.

Ratageri VH, Shepur TA, Patil MM, Hakeem MA. Scurvy in infantile tremor syndrome. Indian J Pediatr. 2005 Oct;72:10:883-4.

Gupte S. Infantile tremor syndrome. Gupte S, editörs. The Short Textbook of Paediatrics. 10th edn. New Delhi; 2004. p. 716–719.

Dror DK, Allen LH. Effect of vitaminB12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev. 2008;66:250–255.

Sezer RG, Bozaykut A, Akoğlu HA, Özdemir GN. The Efficacy of Oral Vitamin B12 Replacement for Nutritional Vitamin B12 Deficiency. J Pediatr Hematol Oncol. 2018 Mar;40:2:e69-e72.

Bahadir A, Reis PG, Erduran E. Oral vitamin B12 treatment is effective for children with nutritional vitamin B12 deficiency. J Paediatr Child Health. 2014 Sep;50:9:721-5.

Ozdemir O, Baytan B, Gunes AM, Okan M. Involuntary movements during vitamin B12 treatment. J Child Neurol. 2010 Feb;25:2:227-30.

Bagley P, Shane B. Folate. Coates PM, Blackman MR, Betz JM, Cragg GM, Levine M, Moss J, White JD, editors. Encyclopedia of Dietary Supplements. 2nd ed. Newyork:2015.p.218-229.

Watkins D, Whitehead VM, Rosenblatt DS. Megaloblastic anemia. Orkin SH, Ginsburg D, Nathan DA, editors. Nathan and Oski’s Hematology of Infancy and Childhood. 7th edn. Philadelphia; 2009. p.467–520.

Green R, Datta Mitra A. Megaloblastic Anemias: Nutritional and Other Causes. Med Clin North Am. 2017 Mar;101:2:297-317.

Liu H, Li W, Zhao S, et al. Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells. Eur J Nutr. 2016 Aug;55:5:1849-62.

Martini L, Pecoraro L, Salvottini C, Piacentini G, Atkinson R, Pietrobelli A. Appropriate and inappropriate vitamin supplementation in children. J Nutr Sci. 2020 Jun 5;9:e20.

Ebara S. Nutritional role of folate. Congenit Anom (Kyoto). 2017 Sep;57(5):138-141.

Adhikari PM, Chowta MN, Ramapuram JT, Rao S, Udupa K, Acharya SD. Prevalence of Vitamin B12 and folic acid deficiency in HIV-positive patients and its association with neuropsychiatric symptoms and immunological response. Indian J Sex Transm Dis AIDS. 2016 Jul-Dec;37:2:178-184.

Trujillo J, Vieira MC, Lepsch J, et al. A systematic review of the associations between maternal nutritional biomarkers and depression and/or anxiety during pregnancy and postpartum. J Affect Disord. 2018 May;232:185-203.

Refsum H, Ueland PM, Nygard O. Vollset, S.E. Homocysteine and vascular disease. Annu. Rev. Med. 1998, 49, 31–62.

De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, et al. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010 Oct 6;(10):CD007950.

Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006 Nov;5:11:949-60.

Zhao R, Min SH, Qiu A, et al. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood. 2007 Aug 15;110:4:1147-52.

Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004 Dec;46:12:843-51.

Steinfeld R, Grapp M, Kraetzner R, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet. 2009 Sep;85:3:354-63.

Cario H, Bode H, Debatin KM, Opladen T, Schwarz K. Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment. Neurology. 2009 Dec 15;73:24):2127-9.

Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol. 2004 Dec;46:12:843-51.

Mock DM. Biotin. Ziegler EE, Filer LJ, Editors. In Present Knowledge in Nutrition. 7th Ed. Washington DC: International Life Sciences Institutes— Nutrition Foundation: 1996. p. 220-235.

Krause KH, Berlit P, Bonjour JP. Impaired biotin status in anticonvulsant therapy. Ann Neurol. 1982 Nov;12(5):485-6.

Velázquez A, Martín-del-Campo C, Báez A, Zamudio S, et al. Biotin deficiency in protein-energy malnutrition. Eur J Clin Nutr. 1989 Mar;43:3:169-73.

Tourbah A, Lebrun-Frenay C, Edan G et al. (highdose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler. 2016 Sep 1.

Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab. 2010 May;100:1:6-13.

Ozand PT, Gascon GG, Al Essa M, et al. Biotin-responsive basal ganglia disease: a novel entity. Brain. 1998 Jul;121:Pt 7:1267-79.

Zeng WQ, Al-Yamani E, Acierno JS Jr, Slaugenhaupt S, Gillis T, MacDonald ME, Ozand PT, Gusella JF. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet. 2005 Jul;77(1):16-26.

Tabarki B, Al-Hashem A, Alfadhel M. Biotin-Thiamine-Responsive Basal Ganglia Disease. 2013 Nov 21 [updated 2020 Aug 20]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. [updated 2020 Aug 20]. Seattle (WA): University of Washington, Seattle; 1993–2021.

Kamaşak T, Havalı C, İnce H, et al. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease? Eur J Paediatr Neurol. 2018 Nov;22:6:1139-1149.

Debs R, Depienne C, Rastetter A, Bellanger A, Degos B, Galanaud D, Keren B, Lyon-Caen O, Brice A, Sedel F. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. Arch Neurol. 2010 Jan;67;1:126-30.

Yamada K, Miura K, Hara K, et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet. 2010 Dec 22;11:171.

Baxter P. Pyridoxine-dependent and pyridoxine-responsive seizures. Dev Med Child Neurol. 2001 Jun;43:6:416-20.

Wang HS, Kuo MF, Chou ML, et al. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Arch Dis Child. 2005 May;90:5:512-5.

Hunt AD, Stokes J, Mccrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics. 1954 Feb;13:2:140-5.

Hellström-Westas L, Blennow G, Rosén I. Amplitude-integrated encephalography in pyridoxine-dependent seizures and pyridoxine-responsive seizures. Acta Paediatr. 2002;91:8:977-80

Coker SB. Postneonatal vitamin B6-dependent epilepsy. Pediatrics. 1992 Aug;90:2 Pt 1:221-3.

Goutières F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985 Feb;17:2:117-20.

Grillo E, da Silva RJ, Barbato JH Jr. Pyridoxine-dependent seizures responding to extremely low-dose pyridoxine. Dev Med Child Neurol. 2001 Jun;43:6:413-5.

Bass NE, Wyllie E, Cohen B, Joseph SA. Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol. 1996 Sep;11:5:422-4.

Baxter P. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK. Arch Dis Child. 1999 Nov;81:5:431-3.

Basura GJ, Hagland SP, Wiltse AM, Gospe SM Jr. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediatr. 2009 Jun;168:6:697-704.

Mefford HC, Zemel M, Geraghty E, et al. Cook J, Clayton PT, Paul K, Plecko B, Mills PB, Nordli DR Jr, Gospe SM Jr. Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination. Neurology. 2015 Sep 1;85:9:756-62.

Gospe SM. Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr Neurol. 2002 Mar;26:3:181-5.

Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007 May;65:442-55.

Fattal-Valevski A, Kesler A, Sela BA, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics. 2005 Feb;115:2:e233-8.

Hartman AL, Comi AM. Mitochondrial Diseases. Singer HS, Kossoff EH, Hartman AL, Crawford TO, editors. Treatment of Pediatric Neurologic Disorders. 1 st edition. Taylor & Francis Group; 2005. p. 385-390.

Joosten V, van Berkel WJ. Flavoenzymes. Curr Opin Chem Biol. 2007 Apr;11:2:195-202.

Lienhart WD, Gudipati V, Macheroux P. The human flavoproteome. Arch Biochem Biophys. 2013;535:2:150-162.

Kennedy DO. B Vitamins and the brain: mechanisms, dose and efficacy – a review. Nutrients. 2016;8:2:68.

Buehler BA. Vitamin B2: Riboflavin. J Evid-Based Complementary Altern Med. 2011;16:2:88-90.

Smith LD, Garg U. Disorders of vitamins and cofactors. Garg U, Smith LD, editors. Biomarkers in Inborn Errors of Metabolism. 1 st edition. Elsevier; 2017. P. 361-397.

Foley AR, Menezes MP, Pandraud A, et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan;137:(Pt 1):44-56.

Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014 Sep;5:5:503-14.

Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2003;(4):CD003665.

Martini L, Pecoraro L, Salvottini C, Piacentini G, Atkinson R, Pietrobelli A. Appropriate and inappropriate vitamin supplementation in children. J Nutr Sci. 2020 Jun 5;9:e20.

Jayaram S, Soman A, Tarvade S, Londhe V. Cerebellar ataxia due to isolated vitamin E deficiency. Indian J Med Sci. 2005 Jan;59:1:20-3.

Di Donato I, Bianchi S, Federico A. Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci. 2010 Aug;31:4:511-5.

Rader DJ, Brewer HB Jr. Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease. JAMA. 1993 Aug 18;270:7:865-9.

Lippi G, Franchini M. Vitamin K in neonates: facts and myths. Blood Transfus. 2011 Jan;9:1:4-9.

Van Winckel M, De Bruyne R, Van De Velde S, Van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr. 2009 Feb;168:2:127-34.

Autret-Leca E, Jonville-Béra AP. Vitamin K in neonates: how to administer, when and to whom. Paediatr Drugs. 2001;3:1:1-8.

Ozdemir MA, Karakukcu M, Per H, Unal E, Gumus H, Patiroglu T. Late-type vitamin K deficiency bleeding: experience from 120 patients. Childs Nerv Syst. 2012 Feb;28:2:247-51.

Misirlioglu ED, Aliefendioglu D, Bademci G, Baydar Z, Kose G, Cakm FN. Intracranial hemorrhage due to vita- min k deficiency in infancy: clinical and radiological findings. J Neurosurg Sci. 2009;26:1:18–25.

Ramakrishna T. Vitamins and brain development. Physiol Res. 1999;48:3:175-87.

Kasarskis EJ, Bass NH. Benign intracranial hypertension induced by deficiency of vitamin A during infancy. Neurology. 1982 Nov;32:11:1292-5.

Underwood BA, Smitasiri S. Micronutrient malnutrition: policies and programs for control and their implications. Annu Rev Nutr. 1999;19:303-24.

Pecoraro L, Martini L, Antoniazzi F, Piacentini G, Pietrobelli A. Vitamin C: should daily administration keep the paediatrician away? Int J Food Sci Nutr. 2019 Jun;70:4:513-517.

Velandia B, Centor RM, McConnell V, Shah M. Scurvy is still present in developed countries. J Gen Intern Med. 2008 Aug;23:8:1281-4.

Amr M, El-Mogy A, Shams T, Vieira K, Lakhan SE. Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. Nutr J. 2013 Mar 9;12:31.

Carr AC, McCall C. The role of vitamin C in the treatment of pain: new insights. J Transl Med. 2017 Apr 14;15:1:77.

Aïm F, Klouche S, Frison A, Bauer T, Hardy P. Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: A systematic review and meta-analysis. Orthop Traumatol Surg Res. 2017 May;103:3:465-470.